The P2Y₁ Receptor Antagonist Adenosine-2’,5’-Diphosphate Non-selectively Antagonizes the Platelet P2X₁ Ion Channel

• References

• 1 Ravelic V, and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-92.
• 2 Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2281-5.
• 3 Mahaut-Smith MP, Ennion SJ, Rolf MG, Evans RJ. ADP is not an agonist at P2X₁ receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 2000; 131: 108-14.
• 4 Rolf MG, Brearley CA, Mahaut-Smith MP. Platelet shape change evoked by selective activation of P2X₁ purinoceptors with α,β-methylene ATP. Thromb Haemost 2001; 85: 303-8.
• 5 Oury C, Toth-Zsamboki E, Thys C, Tytgat J, Vermylen J, Hoylaerts M. The ATP-gated P2X₁ ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 2001; 86: 1264-71.
• 6 Boyer JL, Mohanram A, Camaioni E, Jacobson KA, Harden TK. Competitive and selective antagonism of P2Y₁ receptors by N6-methyl 2′-deoxyadenosine 3′,5′-biphosphate. Br J Pharmacol 1998; 124: 1-3.
• 7 Brown SG, King BF, Kim YC, Jang SY, Burnstock G, Jacobson KA. Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors. Drug Dev Res 2000; 49: 253-9.
• 8 Boyer JL, Romero-Avila T, Schchter JB, Harden TK. Identification of competitive antagonists of the P2Y₁ receptor. Mol Pharmacol 1996; 50: 1323-9.
• 9 Eckly A, Gendrault J-L, Hechler B, Cazenave J-P, Gachet C. Differential involvement of the P2Y₁ and P2Y_T receptors in the morphological changes of platelet aggregation. Thromb Haemost 2001; 85: 694-701.
• 10 Oury C, Toth-Zsamboki E, Van Geet C, Thys C, Wei L, Nilius B, Vermylen J, Hoylaerts MF. A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue. J Biol Chem 2000; 275: 22611-4.
• 11 Deckmyn H, Stanssens P, Hoet B, Declerck PJ, Lauwereys M, Gansemans Y, Tornai I, Vermylen J. An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function. Br J Haematol 1994; 87: 562-71.